Analysis: Nutrisystem (NASDAQ:NTRI) Stock Target Upgraded Today
In an analyst note revealed to clients and investors by Citigroup on Wednesday morning, the firm, Nutrisystem (NASDAQ:NTRI), had their target price per share lowered to $30.00. Analusts now have a solid Buy rating on the stock.
From a total of 6 analysts covering Nutrisystem (NASDAQ:NTRI) stock, 6 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is $39 while the lowest target price is $28. The mean of all analyst targets is $34.5 with a 41.27% above today’s ($23.36) stock price. Nutrisystem was the topic of 5 analyst reports since July 24, 2015 according to the firm StockzIntelligence Inc. Sidoti upgraded shares on November 2 to “Buy” rating. B. Riley & Co maintained NTRI stock in a recent report from October 29 with “Buy” rating. Finally, Lake Street initiated the stock with “Buy” rating in a report issued on a July 24.
It is down 18.58% since April 29, 2015 and is uptrending. It has outperformed by 18.78% the S&P500.
Nutrisystem, Inc. is a well-known provider of weight management services and products, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The company has a market cap of $681.60 million. The Company’s program clients purchase monthly food packages containing a 28-day supply of breakfasts, lunches, dinners, snacks and desserts, which they supplement with fresh fruits, vegetables and dairy. It has 24.94 P/E ratio. The Company’s clients order on an auto-delivery basis (Auto-Delivery), where it sends a 28-day food supply on an ongoing basis until notified of a customer’s cancellation.
According to Zacks Investment Research, “NutriSystem is a leading provider of weight management products and services. They offer an at-home weight loss program based on portion-controlled, lower Glycemic Index prepared meals, weight loss plans, and private telephone and online support.” Get a free copy of the Zacks research report on NutriSystem Inc. (NTRI).